In-vitro inhibition of human erythrocyte acetylcholinesterase by Salvia lavandulaefolia essential oil and constituent terpenes

Journal of Pharmacy and Pharmacology

Volumn 52, Issue 7, 2000, Pages 895-902

  Perry, Nicolette S L ^d   Houghton, Peter J ^a   Theobald, Anthony ^a   Jenner, Peter ^b   Perry, Elaine K ^c  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINESTERASE; BETA PINENE; BORNYL ACETATE; CAMPHOR; CINEOLE; ESSENTIAL OIL; GERANIOL; LIMONENE; LINALOOL; SALVIA LAVANDULAEFOLIA EXTRACT; TERPENE; TERPINENE; TERPINEOL; UNCLASSIFIED DRUG;

ANGIOSPERM; ARTICLE; ENZYME INHIBITION; ERYTHROCYTE; HUMAN; SALVIA LAVANDULAEFOLIA;

SALVIA LAVANDULAEFOLIA;

EID: 0033913221     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1211/0022357001774598     Document Type: Article

References (36)

1. Agid, Y., Graybiel, A., Ruberg, M., Hirsch, E., Brandel, J.-P., Cervera, J. J., Lehericy, S., Malessa, S., Ransmayr, G., Javoy-Agid, F. (1990) Cholinergic systems in Alzheimer's disease, Parkinson's disease and progressive supranuclear palsy. In: Nagatsu, T. (ed.) Basic, Clinical, and Therapeutic Aspects of Alzheimer's and Parkinson's Disease. Volume 1, Plenum Press, New York, pp 427-430
2. Al-Jafari, A. A. (1997) The inhibitory effect of the neuromuscular blocking agent gallamine triethiodide, on camel retina acetylcholinesterase activity. Toxicol. Lett. 90: 45-51
3. Al-Jafari, A. A., Kamal, M. A. (1996) Optimization and kinetic studies of human erythrocyte membrane-bound acetylcholinesterase. Biochem. Mol. Biol. Int. 38: 577-586
4. Bhattacharya, S. K., Kumar, A., Ghosal, S. (1995) Effects of glycowithanolides from Withania somnifera on an animal model of Alzheimer's disease and perturbed central cholinergic markers in rats. Phytother. Res. 9: 110-113
5. Chemnitius, J.-M., Haselmeyer, K.-H., Gonska, B.-D., Kreuzer, H., Zech, R. (1996) Indirect parasympathomimetic activity of metoclopramide: reversible inhibition of cholinesterases from human central nervous system and blood. Pharmacol. Res. 34: 65-72
6. Christenson, W. R., Van Goethem, D. L., Schroeder, R. S., Wahle, B. S., Dass, P. D., Sangha, G. K., Thyssen, J. H. (1994) Interlaboratory cholinesterase determinations and the effect on the results of statistical evaluation of cholinesterase inhibition. Toxicol. Lett. 71: 139-150
7. Court, J. A., Perry, E. K. (1991) Dementia: the neurochemical basis of putative transmitter orientated therapy. Pharmacol. Ther. 52: 423-443
8. Cummings, B. J., Pike, C. J., Shankle, R., Cotman, C. W. (1996) β-Amyloid deposition and other measures of neuropathology predict cognitive status in Alzheimer's disease. Neurobiol. Aging 17: 921-933
9. Ellman, G. L., Courtney, K. D., Andres, V., Featherstone, R. M. (1961) A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 7: 88-95
10. Engel, P. C. (1981) Enzyme Kinetics: The Steady-State Approach. Chapman & Hall, London, pp 14-36
11. Fersht, A. (1977) Enzyme Structure and Mechanism. W. H. Freeman & Co. Ltd, pp 84-94
12. Fulton, B., Benfield, P. (1996) Galanthamine. Drugs Aging 1: 60-65
13. Gracza, L. (1985) Molecular and pharmacological investigation of medicinal plant substances II. Inhibition of acetylcholinesterase by monoterpene derivatives in vitro. Z. Naturforsch. 40: 151-153
14. Grieve, M. (1980) A Modern Herbal. Penguin Books, UK, pp 700-705
15. Grundy, D. L., Still, C. C. (1985a) Inhibition of acetylcholinesterase by pulegone1-,2 epoxide. Pest. Biochem. Phys. 23: 383-388
16. Grundy, D. L., Still, C. C. (1985b) Isolation and identification of the major insecticidal compound of poleo (Lippia stoechadifolia). Pest. Biochem. Physiol. 23: 378-382
17. m in enzyme reactions. Sci. 116: 329-331
18. Kanowski, S., Herrmann, W. M., Stephan, K., Wierich, W., Hörr, R. (1996) Proof of efficacy of the Ginkgo Biloba special extract Egb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia. Pharmacopsychiatry 29: 47-56
19. Le Bars, P. L., Katz, M. M., Berman, N., Itil, T. M., Freedman, A. M., Schatzberg, A. F. (1997) A placebo-controlled, double-blind, randomised trial of an extract of Ginkgo biloba for dementia. J. Am. Med. Assoc. 278: 1325-1331
20. Melzer, D. (1998) New drug treatment for Alzheimer's disease: lessons for healthcare policy. Br. Med. J. 316: 762-764
21. Miyazawa, M., Watanabe, H., Kameoka, H. (1997) Inhibition of acetylcholinesterase activity by monoterpenoids with a p-menthane skeleton. J. Agric. Food. Chem. 45: 677-679
22. Miyazawa, M., Watanabe, H., Umemoto, K., Kameoka, H. (1998) Inhibition of acetylcholinesterase activity by essential oils of Mentha species. J. Agric. Food. Chem. 46: 3431-3434
23. Park, C. H., Kim, S.-H., Choi, W., Lee, Y.-J., Kim, J. S., Kang, S. S., Suh, Y. H. (1996) Novel anticholinesterase and antiamnesic activities of dehydroevodiamine, a constituent of Evodia rutaecarpa. Planta Medica 62: 405-409
24. Paton, C., Branford, D. B. (1997) Advances in the treatment of Alzheimer's disease. Pharm. J. 259: 693-696
25. Perry, N., Court, G., Bidet, N., Court, J., Perry, E. K. (1996) Cholinergic activities of European herbs and potential for dementia therapy. J. Ger. Psychiatr. 11: 1063-1069
26. Perry, N., Houghton, P. J., Jenner, P. (1997) Inhibition of erythrocyte acetylcholinesterase by droplet counter-current chromatography fractions of Salvia lavandulaefolia oil. J. Pharm. Pharmacol. 49 (Suppl.4): 34
27. Price, N. C., Stevens, L. (1989) Fundamentals of Enzymology. Oxford University Press, UK, pp 143-150
28. Ryan, M. F., Byrne, O. (1988) Plant-insect coevolution and inhibition of acetylcholinesterase. J. Chem. Ecol. 14: 1965-1975
29. Ryman, D. (1991) Aromatherapy. Judy Piakus Publishers, UK, pp 190-194
30. Salvesen, G., Nagase, H. (1989) Inhibition of proteolytic enzymes.In: Beynon, R. J., Bond, J. S. (eds) Proteolytic Enzymes: A Practical Approach. IRL Press, Oxford University, UK, pp 83-87
31. Schliebs, R., Liebmann, A., Bhattacharya, S. K., Kumar, A., Ghosal, S., Bigl, V. (1997) Systemic administration of defined extracts from Withania somnifera (Indian Ginseng) and Shilajit differentially affects cholinergic but not glutamatergic and gabaergic markers in rat brain. Neurochem. Int. 30: 181-190
32. Schneider, L. S. (1996) New therapeutic approaches to Alzheimer's disease. J. Clin. Psychiatry 57 (Suppl. 14): 30-36
33. Small, G. W., Rabins, R. V., Barry, P. P., Buckholtz, N. S., DeKosky, S. T., Ferris, S. H., Finkel, S. I., Gwyther, L. P., Khachaturian, Z. S., Lebowitz, B. D., McRae, T. D., Morris, J. C., Oakley, F., Schneider, L. S., Streim, J. E., Sunderland, T., Teri, L. A., Tune, L. E. (1997) Diagnosis and treatment of Alzheimer disease and related disorders. J. Am. Med. Assoc. 278: 1363-1371
34. Stahl, E. (1969) Thin-Layer Chromatography: A Laboratory Handbook. 2nd edn, Springer-Verlag, Berlin
35. Tang, X. C. (1994) Neuropharmacological effect of active principle isolated from Chinese medicinal herbs. Neuropschychopharmacology 10 (3S/2): 691S
36. Tyler, V. E. (1993) The Honest Herbal. 3rd edn, Pharmaceutical Products Press, US, pp 271-273